MedPath
FDA Approval

Docosanol

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
May 8, 2025
Labeling Type
HUMAN OTC DRUG LABEL
Docosanol(100 mg in 1 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

871411532

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Docosanol

Product Details

NDC Product Code
46708-682
Application Number
ANDA215839
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
May 8, 2025
DocosanolActive
Code: 9G1OE216XYClass: ACTIBQuantity: 100 mg in 1 g
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACT
LIGHT MINERAL OILInactive
Code: N6K5787QVPClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SUCROSE DISTEARATEInactive
Code: 33X4X4B90SClass: IACT
SUCROSE STEARATEInactive
Code: 274KW0O50MClass: IACT
© Copyright 2025. All Rights Reserved by MedPath